Azurity Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals, Inc. > Summary
Court Case Number 1:23-cv-01080
Filing Date Sep 29, 2023
Termination Date May 14, 2024
Court Delaware District Court
Status Dismissed - Other
JudgesMaryellen Noreika
Defendant
Plaintiff Attorneys
9Azurity Pharmaceuticals, Inc.
Attorney Name: Sarah E. Spencer
Paul Hastings
Takeda Pharmaceutical Company Limited
Attorney Name: Alexandra M. Joyce
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Maliheh Zare
McCarter & English
Arbor Pharmaceuticals
Attorney Name: Bruce M. Wexler
Paul Hastings
Arbor Pharmaceuticals
Attorney Name: Chad J. Peterman
Paul Hastings
Arbor Pharmaceuticals
Attorney Name: Christopher P. Hill
Paul Hastings
Arbor Pharmaceuticals
Attorney Name: Michael F. Werno
Paul Hastings
Takeda Pharmaceutical Company Limited
Attorney Name: Zhiqiang Liu
Patterson Belknap Webb & Tyler
Defendant Attorneys
7Teva Pharmaceuticals
Attorney Name: Danielle Zapata
Greenberg Traurig LLP
Teva Pharmaceuticals
Attorney Name: Elana B. Araj
Greenberg Traurig LLP
Teva Pharmaceuticals
Attorney Name: Jonathan D. Ball
Greenberg Traurig LLP
Teva Pharmaceuticals
Attorney Name: Karen E. Keller
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Kathryn E. Albanese
Greenberg Traurig LLP
Teva Pharmaceuticals
Attorney Name: Nathan R. Hoeschen
Shaw Keller LLP
Teva Pharmaceuticals
Attorney Name: Scott J. Bornstein
Greenberg Traurig LLP
Related Patents
Doc No | Title | Issue date |
---|---|---|
09387249 | Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone | Jul 12, 2016 |
09169238 | Solid pharmaceutical composition | Oct 27, 2015 |
09066936 | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent | Jun 30, 2015 |
07572920 | Benzimidazole derivative and use as a II receptor antagonist | Aug 11, 2009 |
07157584 | Benzimidazole derivative and use thereof | Jan 2, 2007 |
04951033 | Input device of character data | Aug 21, 1990 |